Vimarsana
Biggest News Aggregation in the World

Page 5 - Stent System News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Stent System. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Stent System Today - Breaking & Trending Today

Head-To-Head Contrast: Silk Road Medical (NASDAQ:SILK) and Vivos Therapeutics (NASDAQ:VVOS) - Vimarsana News

Head-To-Head Contrast: Silk Road Medical (NASDAQ:SILK) and Vivos Therapeutics (NASDAQ:VVOS)

Vivos Therapeutics (NASDAQ:VVOS – Get Free Report) and Silk Road Medical (NASDAQ:SILK – Get Free Report) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their earnings, valuation, dividends, risk, institutional ownership, analyst recommendations and profitability. Valuation and Earnings This table compares […]

Research Analysts' Weekly Ratings Changes for Silk Road Medical (SILK) - Vimarsana News

Research Analysts' Weekly Ratings Changes for Silk Road Medical (SILK)

Several analysts have recently updated their ratings and price targets for Silk Road Medical (NASDAQ: SILK): 10/24/2023 – Silk Road Medical was upgraded by analysts at Wolfe Research from an “underperform” rating to a “peer perform” rating. 10/11/2023 – Silk Road Medical was downgraded by analysts at Citigroup Inc. from a “buy” rating to a […]

Late-Breaking Clinical Trial Results Announced at The VEINS 2023 - Vimarsana News

Late-Breaking Clinical Trial Results Announced at The VEINS 2023

/PRNewswire/ -- The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and...

Piper Sandler Trims Silk Road Medical (NASDAQ:SILK) Target Price to $11.00 - Vimarsana News

Piper Sandler Trims Silk Road Medical (NASDAQ:SILK) Target Price to $11.00

Silk Road Medical (NASDAQ:SILK – Free Report) had its price target cut by Piper Sandler from $25.00 to $11.00 in a research report sent to investors on Wednesday, Benzinga reports. They currently have a neutral rating on the stock. Several other research analysts have also weighed in on the company. Stifel Nicolaus lowered Silk Road […]

Piper Sandler Lowers Price Target on Silk Road Medical to $11 From $25, Maintains Neutral Rating - Vimarsana News

Piper Sandler Lowers Price Target on Silk Road Medical to $11 From $25, Maintains Neutral Rating

-- Silk Road Medical has an average hold rating and price target range of $11 to $35, according to analysts polled by Capital IQ. Price: 6.74, Change: -7.25, Percent Change: -51.86 ...